Lipoatrophy, a rare complication of diabetes: a single-center experience View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-10-21

AUTHORS

Maria Xatzipsalti, Hlias Alvertis, Giannoula Kourousi, Konstantina Patouni, Sotiris Konstantakopoulos, Dimitris Delis, Andriani Vazeou

ABSTRACT

BackgroundLipoatrophy (LA), a rare skin complication in patients with type 1 diabetes (T1D), has decreased dramatically over the past decades due to the use of human purified insulin preparations.MethodsWe collected data from the records of T1D patients with LA. Types of insulin and insulin regimen, presence of eosinophilia, anti-insulin (IAA), anti-GAD, anti-IA2 autoantibodies, other autoimmune disorders, site of atrophy and its relationship to catheter, HbA1c at LA onset and after resolution, and different treatment modalities (i.e., change of insulin type or site, sodium cromoglycate (SCG) cream, cortisone cream or percutaneous injections, and laser treatment) were recorded.ResultsThirteen out of 1200 T1D subjects (1%) presented with LA. The majority were on insulin pump using rapid-acting analogs. Twelve out of 13 patients had changed the type of insulin, and most of them had switched injection sites. Ten out of 13 patients used SCG cream and 7/10 showed complete/partial improvement. One patient used dexamethasone injection with improvement. Five patients showed self-improvement. In 3/7 patients who were receiving SCG, treatment was combined with change of insulin type (glulisine); however, in 1/3, the result should be attributed to concomitant laser treatment. In 4/7 patients, there was a clear, beneficial effect of SCG. In 1/4 with partial resolution of LA, laser treatment was used after SCG, which further improved the result.ConclusionsLA is a rare skin complication seen even today with the use of insulin analogs. SCG alone or combined with change of insulin type seems to be the most effective treatment. Laser treatment is a promising new therapy. More... »

PAGES

61-69

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s42000-021-00324-z

DOI

http://dx.doi.org/10.1007/s42000-021-00324-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142031071

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34671939


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Infusion Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipodystrophy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xatzipsalti", 
        "givenName": "Maria", 
        "id": "sg:person.014104134117.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014104134117.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dermatology Private Office, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Dermatology Private Office, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alvertis", 
        "givenName": "Hlias", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kourousi", 
        "givenName": "Giannoula", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patouni", 
        "givenName": "Konstantina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konstantakopoulos", 
        "givenName": "Sotiris", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Delis", 
        "givenName": "Dimitris", 
        "id": "sg:person.013126052413.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013126052413.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.417354.0", 
          "name": [
            "Diabetes Center, A\u2019 Department of Pediatrics, P&A Kyriakou Children\u2019s Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vazeou", 
        "givenName": "Andriani", 
        "id": "sg:person.0705145351.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705145351.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s40842-015-0013-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023842777", 
          "https://doi.org/10.1186/s40842-015-0013-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250051476", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023117742", 
          "https://doi.org/10.1007/s001250051476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00128071-200708010-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009634301", 
          "https://doi.org/10.2165/00128071-200708010-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1758-5996-3-33", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006180689", 
          "https://doi.org/10.1186/1758-5996-3-33"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-21", 
    "datePublishedReg": "2021-10-21", 
    "description": "Abstract\nBackgroundLipoatrophy (LA), a rare skin complication in patients with type 1 diabetes (T1D), has decreased dramatically over the past decades due to the use of human purified insulin preparations.MethodsWe collected data from the records of T1D patients with LA. Types of insulin and insulin regimen, presence of eosinophilia, anti-insulin (IAA), anti-GAD, anti-IA2 autoantibodies, other autoimmune disorders, site of atrophy and its relationship to catheter, HbA1c at LA onset and after resolution, and different treatment modalities (i.e., change of insulin type or site, sodium cromoglycate (SCG) cream, cortisone cream or percutaneous injections, and laser treatment) were recorded.ResultsThirteen out of 1200 T1D subjects (1%) presented with LA. The majority were on insulin pump using rapid-acting analogs. Twelve out of 13 patients had changed the type of insulin, and most of them had switched injection sites. Ten out of 13 patients used SCG cream and 7/10 showed complete/partial improvement. One patient used dexamethasone injection with improvement. Five patients showed self-improvement. In 3/7 patients who were receiving SCG, treatment was combined with change of insulin type (glulisine); however, in 1/3, the result should be attributed to concomitant laser treatment. In 4/7 patients, there was a clear, beneficial effect of SCG. In 1/4 with partial resolution of LA, laser treatment was used after SCG, which further improved the result.ConclusionsLA is a rare skin complication seen even today with the use of insulin analogs. SCG alone or combined with change of insulin type seems to be the most effective treatment. Laser treatment is a promising new therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s42000-021-00324-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1030758", 
        "issn": [
          "1109-3099", 
          "2520-8721"
        ], 
        "name": "Hormones", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "rare skin complication", 
      "type of insulin", 
      "skin complications", 
      "insulin type", 
      "laser treatment", 
      "presence of eosinophilia", 
      "site of atrophy", 
      "single-center experience", 
      "rapid-acting analogues", 
      "different treatment modalities", 
      "promising new therapy", 
      "type 1 diabetes", 
      "Anti-GAD", 
      "insulin regimen", 
      "T1D subjects", 
      "rare complication", 
      "T1D patients", 
      "autoimmune disorders", 
      "dexamethasone injection", 
      "treatment modalities", 
      "effective treatment", 
      "new therapies", 
      "partial improvement", 
      "patients", 
      "insulin preparations", 
      "injection site", 
      "insulin analogues", 
      "insulin pump", 
      "complications", 
      "beneficial effects", 
      "treatment", 
      "diabetes", 
      "partial resolution", 
      "insulin", 
      "HbA1c", 
      "eosinophilia", 
      "regimen", 
      "autoantibodies", 
      "lipoatrophy", 
      "atrophy", 
      "catheter", 
      "ConclusionsLA", 
      "therapy", 
      "MethodsWe", 
      "disorders", 
      "modalities", 
      "injection", 
      "onset", 
      "cream", 
      "subjects", 
      "past decade", 
      "improvement", 
      "majority", 
      "SCG", 
      "changes", 
      "use", 
      "types", 
      "analogues", 
      "records", 
      "sites", 
      "effect", 
      "experience", 
      "presence", 
      "results", 
      "data", 
      "relationship", 
      "pump", 
      "La", 
      "preparation", 
      "decades", 
      "resolution", 
      "today"
    ], 
    "name": "Lipoatrophy, a rare complication of diabetes: a single-center experience", 
    "pagination": "61-69", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142031071"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s42000-021-00324-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34671939"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s42000-021-00324-z", 
      "https://app.dimensions.ai/details/publication/pub.1142031071"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_890.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s42000-021-00324-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00324-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00324-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00324-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00324-z'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      22 PREDICATES      108 URIs      96 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s42000-021-00324-z schema:about N3d91302107cb404ea5a1f418d5c4d62d
2 N8c531a10a74f4e8da0c1211a58e33dde
3 N90bb0e6cebd749cbbb4b10cf34e955da
4 Nd6290d9a51d241c78508f825376a1a5f
5 Nf8659963aa3b43029cef4c15001c78a0
6 Nff20129018254b1aa20e701e610dad67
7 anzsrc-for:11
8 anzsrc-for:1103
9 schema:author N408a59bdbfe84c64bcadda0c9b4334e7
10 schema:citation sg:pub.10.1007/s001250051476
11 sg:pub.10.1186/1758-5996-3-33
12 sg:pub.10.1186/s40842-015-0013-5
13 sg:pub.10.2165/00128071-200708010-00003
14 schema:datePublished 2021-10-21
15 schema:datePublishedReg 2021-10-21
16 schema:description Abstract BackgroundLipoatrophy (LA), a rare skin complication in patients with type 1 diabetes (T1D), has decreased dramatically over the past decades due to the use of human purified insulin preparations.MethodsWe collected data from the records of T1D patients with LA. Types of insulin and insulin regimen, presence of eosinophilia, anti-insulin (IAA), anti-GAD, anti-IA2 autoantibodies, other autoimmune disorders, site of atrophy and its relationship to catheter, HbA1c at LA onset and after resolution, and different treatment modalities (i.e., change of insulin type or site, sodium cromoglycate (SCG) cream, cortisone cream or percutaneous injections, and laser treatment) were recorded.ResultsThirteen out of 1200 T1D subjects (1%) presented with LA. The majority were on insulin pump using rapid-acting analogs. Twelve out of 13 patients had changed the type of insulin, and most of them had switched injection sites. Ten out of 13 patients used SCG cream and 7/10 showed complete/partial improvement. One patient used dexamethasone injection with improvement. Five patients showed self-improvement. In 3/7 patients who were receiving SCG, treatment was combined with change of insulin type (glulisine); however, in 1/3, the result should be attributed to concomitant laser treatment. In 4/7 patients, there was a clear, beneficial effect of SCG. In 1/4 with partial resolution of LA, laser treatment was used after SCG, which further improved the result.ConclusionsLA is a rare skin complication seen even today with the use of insulin analogs. SCG alone or combined with change of insulin type seems to be the most effective treatment. Laser treatment is a promising new therapy.
17 schema:genre article
18 schema:inLanguage en
19 schema:isAccessibleForFree false
20 schema:isPartOf N57d1d8f786494552bcb1a56d1fdce384
21 Ne799079bd8674a79bc057b3d8601b0ab
22 sg:journal.1030758
23 schema:keywords Anti-GAD
24 ConclusionsLA
25 HbA1c
26 La
27 MethodsWe
28 SCG
29 T1D patients
30 T1D subjects
31 analogues
32 atrophy
33 autoantibodies
34 autoimmune disorders
35 beneficial effects
36 catheter
37 changes
38 complications
39 cream
40 data
41 decades
42 dexamethasone injection
43 diabetes
44 different treatment modalities
45 disorders
46 effect
47 effective treatment
48 eosinophilia
49 experience
50 improvement
51 injection
52 injection site
53 insulin
54 insulin analogues
55 insulin preparations
56 insulin pump
57 insulin regimen
58 insulin type
59 laser treatment
60 lipoatrophy
61 majority
62 modalities
63 new therapies
64 onset
65 partial improvement
66 partial resolution
67 past decade
68 patients
69 preparation
70 presence
71 presence of eosinophilia
72 promising new therapy
73 pump
74 rapid-acting analogues
75 rare complication
76 rare skin complication
77 records
78 regimen
79 relationship
80 resolution
81 results
82 single-center experience
83 site of atrophy
84 sites
85 skin complications
86 subjects
87 therapy
88 today
89 treatment
90 treatment modalities
91 type 1 diabetes
92 type of insulin
93 types
94 use
95 schema:name Lipoatrophy, a rare complication of diabetes: a single-center experience
96 schema:pagination 61-69
97 schema:productId N3a8ecd6cfd4749f2a342e4a97262c198
98 N87aab641031241bc8c1f4e9c4d3a046b
99 Nae0a1ebecd49458c9dbf03202baa4918
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142031071
101 https://doi.org/10.1007/s42000-021-00324-z
102 schema:sdDatePublished 2022-05-20T07:39
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N3d4ab26c1cd840c0b2d64d6ca6285f66
105 schema:url https://doi.org/10.1007/s42000-021-00324-z
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N239dd932032c40ec8e99424188f00097 rdf:first N3be46250b28b4ddab6fa480c1ab6e739
110 rdf:rest N91c88da5c32748ca88868ec40d3cb7a1
111 N3a8ecd6cfd4749f2a342e4a97262c198 schema:name doi
112 schema:value 10.1007/s42000-021-00324-z
113 rdf:type schema:PropertyValue
114 N3be46250b28b4ddab6fa480c1ab6e739 schema:affiliation grid-institutes:grid.417354.0
115 schema:familyName Kourousi
116 schema:givenName Giannoula
117 rdf:type schema:Person
118 N3d4ab26c1cd840c0b2d64d6ca6285f66 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 N3d91302107cb404ea5a1f418d5c4d62d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Insulin Infusion Systems
122 rdf:type schema:DefinedTerm
123 N408a59bdbfe84c64bcadda0c9b4334e7 rdf:first sg:person.014104134117.73
124 rdf:rest Nda2e43f872614b2f84bca939dc15b6ce
125 N57d1d8f786494552bcb1a56d1fdce384 schema:issueNumber 1
126 rdf:type schema:PublicationIssue
127 N87aab641031241bc8c1f4e9c4d3a046b schema:name pubmed_id
128 schema:value 34671939
129 rdf:type schema:PropertyValue
130 N8c531a10a74f4e8da0c1211a58e33dde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Diabetes Mellitus, Type 1
132 rdf:type schema:DefinedTerm
133 N90bb0e6cebd749cbbb4b10cf34e955da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Skin
135 rdf:type schema:DefinedTerm
136 N91c88da5c32748ca88868ec40d3cb7a1 rdf:first N9f00beb89dc7480b92853bea412abf55
137 rdf:rest Ne07a5373d2aa4159be7c8542d45adc4e
138 N923841cc1a7d4453b5a41067e5868e81 rdf:first sg:person.013126052413.43
139 rdf:rest Na906e80d8c0e4b52829ffed46e986e5e
140 N9f00beb89dc7480b92853bea412abf55 schema:affiliation grid-institutes:grid.417354.0
141 schema:familyName Patouni
142 schema:givenName Konstantina
143 rdf:type schema:Person
144 Na906e80d8c0e4b52829ffed46e986e5e rdf:first sg:person.0705145351.08
145 rdf:rest rdf:nil
146 Nae0a1ebecd49458c9dbf03202baa4918 schema:name dimensions_id
147 schema:value pub.1142031071
148 rdf:type schema:PropertyValue
149 Nc46dfc0243df40628958027a5fda1974 schema:affiliation grid-institutes:grid.417354.0
150 schema:familyName Konstantakopoulos
151 schema:givenName Sotiris
152 rdf:type schema:Person
153 Nc9844790375a4a02b5fcae131663d99b schema:affiliation grid-institutes:None
154 schema:familyName Alvertis
155 schema:givenName Hlias
156 rdf:type schema:Person
157 Nd6290d9a51d241c78508f825376a1a5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Insulin
159 rdf:type schema:DefinedTerm
160 Nda2e43f872614b2f84bca939dc15b6ce rdf:first Nc9844790375a4a02b5fcae131663d99b
161 rdf:rest N239dd932032c40ec8e99424188f00097
162 Ne07a5373d2aa4159be7c8542d45adc4e rdf:first Nc46dfc0243df40628958027a5fda1974
163 rdf:rest N923841cc1a7d4453b5a41067e5868e81
164 Ne799079bd8674a79bc057b3d8601b0ab schema:volumeNumber 21
165 rdf:type schema:PublicationVolume
166 Nf8659963aa3b43029cef4c15001c78a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Lipodystrophy
168 rdf:type schema:DefinedTerm
169 Nff20129018254b1aa20e701e610dad67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Humans
171 rdf:type schema:DefinedTerm
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
176 schema:name Clinical Sciences
177 rdf:type schema:DefinedTerm
178 sg:journal.1030758 schema:issn 1109-3099
179 2520-8721
180 schema:name Hormones
181 schema:publisher Springer Nature
182 rdf:type schema:Periodical
183 sg:person.013126052413.43 schema:affiliation grid-institutes:grid.417354.0
184 schema:familyName Delis
185 schema:givenName Dimitris
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013126052413.43
187 rdf:type schema:Person
188 sg:person.014104134117.73 schema:affiliation grid-institutes:grid.417354.0
189 schema:familyName Xatzipsalti
190 schema:givenName Maria
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014104134117.73
192 rdf:type schema:Person
193 sg:person.0705145351.08 schema:affiliation grid-institutes:grid.417354.0
194 schema:familyName Vazeou
195 schema:givenName Andriani
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705145351.08
197 rdf:type schema:Person
198 sg:pub.10.1007/s001250051476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023117742
199 https://doi.org/10.1007/s001250051476
200 rdf:type schema:CreativeWork
201 sg:pub.10.1186/1758-5996-3-33 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006180689
202 https://doi.org/10.1186/1758-5996-3-33
203 rdf:type schema:CreativeWork
204 sg:pub.10.1186/s40842-015-0013-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023842777
205 https://doi.org/10.1186/s40842-015-0013-5
206 rdf:type schema:CreativeWork
207 sg:pub.10.2165/00128071-200708010-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009634301
208 https://doi.org/10.2165/00128071-200708010-00003
209 rdf:type schema:CreativeWork
210 grid-institutes:None schema:alternateName Dermatology Private Office, Athens, Greece
211 schema:name Dermatology Private Office, Athens, Greece
212 rdf:type schema:Organization
213 grid-institutes:grid.417354.0 schema:alternateName Diabetes Center, A’ Department of Pediatrics, P&A Kyriakou Children’s Hospital, Athens, Greece
214 schema:name Diabetes Center, A’ Department of Pediatrics, P&A Kyriakou Children’s Hospital, Athens, Greece
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...